Neal N. Iwakoshi
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Neal N. Iwakoshi.
Molecular and Cellular Biology | 2003
Ann-Hwee Lee; Neal N. Iwakoshi; Laurie H. Glimcher
ABSTRACT The mammalian unfolded protein response (UPR) protects the cell against the stress of misfolded proteins in the endoplasmic reticulum (ER). We have investigated here the contribution of the UPR transcription factors XBP-1, ATF6α, and ATF6β to UPR target gene expression. Gene profiling of cell lines lacking these factors yielded several XBP-1-dependent UPR target genes, all of which appear to act in the ER. These included the DnaJ/Hsp40-like genes, p58IPK, ERdj4, and HEDJ, as well as EDEM, protein disulfide isomerase-P5, and ribosome-associated membrane protein 4 (RAMP4), whereas expression of BiP was only modestly dependent on XBP-1. Surprisingly, given previous reports that enforced expression of ATF6α induced a subset of UPR target genes, cells deficient in ATF6α, ATF6β, or both had minimal defects in upregulating UPR target genes by gene profiling analysis, suggesting the presence of compensatory mechanism(s) for ATF6 in the UPR. Since cells lacking both XBP-1 and ATF6α had significantly impaired induction of select UPR target genes and ERSE reporter activation, XBP-1 and ATF6α may serve partially redundant functions. No UPR target genes that required ATF6β were identified, nor, in contrast to XBP-1 and ATF6α, did the activity of the UPRE or ERSE promoters require ATF6β, suggesting a minor role for it during the UPR. Collectively, these results suggest that the IRE1/XBP-1 pathway is required for efficient protein folding, maturation, and degradation in the ER and imply the existence of subsets of UPR target genes as defined by their dependence on XBP-1. Further, our observations suggest the existence of additional, as-yet-unknown, key regulators of the UPR.
Nature Immunology | 2003
Neal N. Iwakoshi; Ann-Hwee Lee; Prasanth Vallabhajosyula; Kevin L. Otipoby; Klaus Rajewsky; Laurie H. Glimcher
The transcription factor X-box binding protein 1 (XBP-1) is essential for the differentiation of plasma cells and the unfolded protein response (UPR). Here we show that UPR-induced splicing of XBP-1 by the transmembrane endonuclease IRE1 is required to restore production of immunoglobulin in XBP-1−/− mouse B cells, providing an integral link between XBP-1, the UPR and plasma cell differentiation. Signals involved in plasma cell differentiation, specifically interleukin-4, control the transcription of XBP-1, whereas its post-transcriptional processing is dependent on synthesis of immunoglobulins during B cell differentiation. We also show that XBP-1 is involved in controlling the production of interleukin-6, a cytokine that is essential for plasma cell survival. Thus, signals upstream and downstream of XBP-1 integrate plasma cell differentiation with the UPR.
Proceedings of the National Academy of Sciences of the United States of America | 2003
Ann-Hwee Lee; Neal N. Iwakoshi; Kenneth C. Anderson; Laurie H. Glimcher
Novel agents that target the proteasome, a proteolytic complex responsible for the degradation of ubiquitinated proteins, have demonstrated remarkable therapeutic efficacy in multiple myeloma, a plasma cell malignancy. However, the mechanism by which these compounds act remains unknown. A signaling pathway called the unfolded protein response (UPR) allows cells to handle the proper folding of proteins. The transcription factor XBP-1, a regulator of the UPR, is also required for plasma cell differentiation, suggesting a link between the UPR and plasma cell differentiation. Here we show that proteasome inhibitors target XBP-1 and the UPR in myeloma cells. Proteasome inhibitors suppress the activity of the translumenal endoplasmic reticulum endoribonuclease/kinase, IRE1α, to impair the generation of the active, spliced XBP-1 species and simultaneously stabilize the unspliced species that acts as a dominant negative. Myeloma cells rendered functionally deficient in XBP-1 undergo increased apoptosis in response to endoplasmic reticulum stress. Identification of compounds that target the activity of IRE1α/XBP-1 may yield novel therapies for the treatment of multiple myeloma and other malignancies that rely on an intact UPR.
The EMBO Journal | 2005
Ann-Hwee Lee; Gerald C. Chu; Neal N. Iwakoshi; Laurie H. Glimcher
The secretory function of cells relies on the capacity of the endoplasmic reticulum (ER) to fold and modify nascent polypeptides and to synthesize phospholipids for the subsequent trafficking of secretory proteins through the ER–Golgi network. We have previously demonstrated that the transcription factor XBP‐1 activates the expression of certain ER chaperone genes and initiates ER biogenesis. Here, we have rescued the embryonic lethality of XBP‐1 deficient fetuses by targeting an XBP‐1 transgene selectively to hepatocytes (XBP‐1−/−;LivXBP1). XBP‐1−/−;LivXBP1 mice displayed abnormalities exclusively in secretory organs such as exocrine pancreas and salivary gland that led to early postnatal lethality from impaired production of pancreatic digestive enzymes. The ER was poorly developed in pancreatic and salivary gland acinar cells, accompanied by decreased expression of ER chaperone genes. Marked apoptosis of pancreatic acinar cells was observed during embryogenesis. Thus, the absence of XBP‐1 results in an imbalance between the cargo load on the ER and its capacity to handle it, leading to the activation of ER stress‐mediated proapoptotic pathways. These data lead us to propose that XBP‐1 is both necessary and sufficient for the full biogenesis of the secretory machinery in exocrine cells.
Immunological Reviews | 2003
Neal N. Iwakoshi; Ann-Hwee Lee; Laurie H. Glimcher
Summary: X‐box binding protein‐1 (XBP‐1) is a transcription factor essential for plasma cell differentiation. XBP‐1 transcripts are found at high levels in plasma cells from rheumatoid synovium and myeloma cell lines. Lymphoid chimeras deficient in XBP‐1 have a profound defect in plasma cell differentiation, with few plasma cells in their periphery and severely reduced serum immunoglobulin levels. When introduced into B‐lineage cells, XBP‐1 initiates plasma cell differentiation. XBP‐1 is also the mammalian homologue of the yeast transcription factor Hac1p, an important component of the unfolded protein response (UPR). The UPR allows cells to tolerate conditions of endoplasmic reticulum (ER) stress caused by misfolded proteins. Studies examining the relationship between plasma cell differentiation, XBP‐1, and the UPR demonstrate that this novel signaling system is vital for plasma cell differentiation. Signals that induce plasma cell differentiation and the UPR cooperate via XBP‐1 to induce terminal B‐cell differentiation. Additionally, XBP‐1 plays an important role in the regulation of interleukin‐6 production, a cytokine essential for plasma cell survival.
Journal of Experimental Medicine | 2005
Boaz Tirosh; Neal N. Iwakoshi; Laurie H. Glimcher; Hidde L. Ploegh
Differentiation of B cells into plasma cells requires X-box binding protein–1 (XBP-1). In the absence of XBP-1, B cells develop normally, but very little immunoglobulin is secreted. XBP-1 controls the expression of a large set of genes whose products participate in expansion of the endoplasmic reticulum (ER) and in protein trafficking. We define a new role for XBP-1 in exerting selective translational control over high and sustained levels of immunoglobulin M (IgM) synthesis. XBP-1−/− and XBP-1+/+ primary B cells synthesize IgM at comparable levels at the onset of stimulation with lipopolysaccharide or CpG. However, later there is a profound depression in synthesis of IgM in XBP-1−/− B cells, notwithstanding similar levels of μmRNA. In marked contrast, lack of XBP-1 does not affect synthesis and trafficking of other glycoproteins, or of immunoglobulin light chains. Contrary to expectation, degradation of proteins from the ER, using TCRα or US11-mediated degradation of class I major histocompatibility complex molecules as substrates, is normal in XBP-1−/− B cells. Furthermore, degradation of membrane μ was unaffected by enforced expression of XBP-1. We conclude that in primary B cells, the XBP-1 pathway promotes synthesis and secretion of IgM, but does not seem to be involved in the degradation of ER proteins, including that of μ chains themselves.
Immunity | 2003
Neal N. Iwakoshi; Ann-Hwee Lee; Laurie H. Glimcher
Abstract Immunoglobulin secreting plasma cells are critical mediators of an effective humoral immune response. In this issue of Immunity, an article by Shapiro-Shelef et al. defines an essential role for the transcription factor Blimp-1 in plasma cell differentiation and preplasma memory B cell formation.
Science | 2004
Umut Ozcan; Qiong Cao; Erkan Yilmaz; Ann-Hwee Lee; Neal N. Iwakoshi; Esra Özdelen; Gürol Tuncman; Cem Z. Görgün; Laurie H. Glimcher; Gökhan S. Hotamisligil
Immunity | 2004
Arthur L. Shaffer; Miriam Shapiro-Shelef; Neal N. Iwakoshi; Ann-Hwee Lee; Shu-Bing Qian; Hong Zhao; Xin Yu; Liming Yang; Bruce Tan; Andreas Rosenwald; Elaine M. Hurt; Emmanuel Petroulakis; Nahum Sonenberg; Jonathan W. Yewdell; Kathryn Calame; Laurie H. Glimcher; Louis M. Staudt
Science | 2006
Claudio Hetz; Paula Bernasconi; Jill K. Fisher; Ann-Hwee Lee; Michael C. Bassik; Bruno Antonsson; Gabriel S. Brandt; Neal N. Iwakoshi; Anna C. Schinzel; Laurie H. Glimcher; Stanley J. Korsmeyer